Chengdu Kaijie Biopharm Co., Ltd - China

Welcome to

Chengdu Kaijie Biopharm Co., Ltd

Free Member

Chengdu Kaijie Biopharm Co., Ltd
China

Home
Company Info
Contact Us
Products Catalog [1]
- GHRP-6, GHRP-2, CJC-1295, Ipamorelin, HGH Fragment , Melanotan2, MGF, PT141, Hexarelin, Melanotan2
Share your thoughts
Language
- English

Company Profile

Company Contact

Name:

Ms. Elaine Yang [Sales]

E-mail:

Send Message

Homepage:

www.kjpep.com

Instant Messaging:

elaine.yan89@gmail.com

Mobile Number:

Phone Number:

Address:

No.258, Segment 1, Industrial Road, Dayi County
Chengdu 611330, Sichuan
China

Average User Review

There is no review for this company - Write a review

Registration Date:

May. 24, 2023

Last Updated:

Apr. 12, 2011

Business Nature:

Manufacturing of Chemicals category

Want to contact this company?

Add to Basket or Send Message

Your inquiry will be recorded in "Member Trade Mail".

Put on Company Partner

Recommend to your friends

Company Brief

Chengdu Kaijie Biopharm Co. Ltd. ( KJBP) is one of the leading peptide manufacturers in China. It was founded in Chengdu in March, 2003 by a team of experienced peptide chemists with a combined industrial experience over 20 years.

KJBP has oriented its business along two main lines: the investigation, development, production and commercialization of generic bulk peptide APIs for the international markets, and custom synthesis service for buliding blocks, amino acid resin and peptide sequences which meet researchersÂ ¡ Â ¯ specific demand worldwide.

Dayi campus in the suburb of Chengdu city provides KJBP with a good infrastructure for both industrial-scale production of peptides and Custom Synthesis.The pharmaceutical grade solid phase peptide synthesis in Dayi campus can meet USP, EP or the requirements of CP, single batches are up to Kg scales.

KJBP has begun to implement the 2008 development plan which is improving quality management standards and increasing production scale.Currently Chinese GMP is accomplished and the US FDA preparatory work is also under way as scheduled.

Our Mission
To combine innovation with excellence by developing and manufacturing quality peptide accompanied by professional and friendly scientific support.

Chengdu Kaijie Biopharm Co. Milestone:

2001 Chengdu Shengnuo Group, which was the core company of Chengdu Kaijie Biopharm Co., was established in 2001. It was composed of the main group of managers from various departments of the top pharmaceutical companies. Becauseof inherent success of peptide synthesis technology, we well prepared for laborary construction in future research and development.
2002 Chengdu Shengnuo Group renovated a small laboratory for the production process. The company purchased R & D Division' s first batch of equipment. Chendu Shengnuo' R & D personnel and the University of Southern California Department of Chemistry held technical exchanges to develop international standards of peptide synthesis methods and research.
2003 Chengdu Kaijie Biopharm Co., Ltd. established its business as peptide product development and customized synthesis service. Added 3 laboratory facilities, laboratory personnel had increased to 12. Improved equipment, imported CSBio automatic peptide synthesis apparatus and multi-flux synthetic instrument, to keep pace with expansion of large custom synthesis business.
2004 The company focused on the development of peptide APIs, Thymosin, and Somatostatin Thymopentin products.
2005 Investment of seventy million yuan was made in Dayi Industrial Park which covers an area of more than ten hectares.
At the same time all aspects of integration and marketing, industry conference and exhibition of International Peptide API were being developed.
2006 Dayi Industrial Park was completed. The new factory was distinguished by three areas of production, peptide synthesis pilot facility, custom peptide synthesis R & D Center, and Generic API workshop.
2007 Company started preparing for examination and approval of related drugs through worlding with University of Cambridge chemists. Facilities in Sichuan Province became one of the fastest growing companies in China.
2008 Chengdu Kaijie Biopharm Co. along with twelve local pharmaceutical companies entered into with the U.S. long-term Raw materials contract, made supply agreements with Europe, India and other places around the world. In the same year, company received thymopentin API GMP certification.
2009 Chengdu Sino-bio Trade Import and Export Trade Co., Ltd, subsidiary of Shengnuo Group, set out to establish international business development relations. Company made preparations for GMP certification, went into production of more 20 new products, and was India' s largest manufacturers of pharmaceutical raw materials imports.
2010 The company started construction of new production plant, expected to be built in 2011 and received U.S. FDA Certification.

I am familiar with this company and want to review it.

You have [3] new inquiries.